Advertisement

Topics

Sutro Biopharma ADC Targeting CD74 Eradicates B-Cell Hematologic Malignancy, Prolongs Survival In Tumor Models

20:00 EDT 2 Apr 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Sutro Biopharma ADC Targeting CD74 Eradicates B-Cell Hematologic Malignancy, Prolongs Survival In Tumor Models

NEXT ARTICLE

More From BioPortfolio on "Sutro Biopharma ADC Targeting CD74 Eradicates B-Cell Hematologic Malignancy, Prolongs Survival In Tumor Models"

Quick Search
Advertisement